CVS HEALTH Corp — Director's Dealing 2021

Jan 13, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2021-01-12

Reporting Person: Bisaccia Lisa (EVP and Chief HR Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-12	Common Stock	M	25177	$74.29	Acquired	71765	Direct
2021-01-12	Common Stock	S	25177	$77.00	Disposed	46588	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-12	Stock Option	$74.29	M	25177	Disposed	2021-04-01	Common Stock (25177)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock (restricted)	6147	Direct
ESOP Common Stock	634	Indirect
Stock Unit	32020.2324	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Phantom Stock Credits	$1.00		Common Stock (468.9237)	468.9237	Direct
Stock Option	$102.26	2022-04-01	Common Stock (34241)	34241	Direct
Stock Option	$104.82	2023-04-01	Common Stock (39433)	39433	Direct
Stock Option	$78.05	2024-04-03	Common Stock (55098)	55098	Direct
Stock Option	$62.21	2025-04-01	Common Stock (64222)	64222	Direct
Stock Option	$54.19	2029-04-01	Common Stock (141405)	141405	Direct
Stock Option	$58.34	2030-04-01	Common Stock (98558)	98558	Direct

Footnotes

F1: All sales were effected pursuant to a Rule 10b5-1 plan.

F2: Option became exercisable in four equal annual installments, commencing 4/1/2015.

F3: Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.

F4: Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.

F5: Option became exercisable in four equal annual installments, commencing 4/1/2016.

F6: Option became exercisable in four equal annual installments, commencing 4/1/2017.

F7: Option became exercisable in four equal annual installments, commencing 4/3/2018.

F8: Option became exercisable in four equal annual installments, commencing 4/1/2019.

F9: Option became exercisable in four equal annual installments, commencing 4/1/2020.

F10: The number of shares subject to the option were calculated using a 30-day average price.

F11: Option becomes exercisable in four equal annual installments, commencing 4/1/2021.